SuspendedNot Applicable

Does a Novel Needle Over Catheter Device Improve First Pass Success and Decrease Complications

Stopped: Manufacturer has suspended for review

United States200 participantsStarted 2025-02

Plain-language summary

Emergency Department Patients who were to get intravenous (IV) access through routine medical care will receive it through trademarked catheter via convenience sample. Patient and clinician experience, including adverse events, will be recorded. A standardized data entry sheet will be collected at time of enrollment, and then daily thereafter while the subject has the IV. The data collected will remain anonymous.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. Any gender, \< 18 years old.
✕. Requirement for emergent IV placement (patient's condition would be compromised if there is a delay in IV placement);
✕. Previous venous grafts or surgery at the target vessel access site;
✕. Currently involved in other investigational clinical trials (unless permission is granted by other study Pl)
✕. Subjects who are pregnant, planning to become pregnant within 3 months of the procedure, or lactating

What they're measuring

Number of Attempts

Timeframe: 10 minutes

Trial details

NCT IDNCT06547294

SponsorCommunity Medical Center, Toms River, NJ

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-04

View on ClinicalTrials.gov More Vascular Access Device Complications trials